CannBioRx Life Sciences Corp Financial Flexibility Index
CannBioRx Life Sciences Corp financial flexibility index. CannBioRx Life Sciences Corp (ATNFW) has a Financial Flexibility Index of -0.21x as of June 2025. Free cash flow of $-1.13 Million (operating CF $-1.13 Million minus capex $4.00) represents 0% of total liabilities ($5.33 Million). See CannBioRx Life Sciences Corp free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of CannBioRx Life Sciences Corp (2017–2024)
Financial flexibility index of CannBioRx Life Sciences Corp from 2017 to 2024. Historical Financial Flexibility Index trend for CannBioRx Life Sciences Corp across 8 annual periods. Check ATNFW cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CannBioRx Life Sciences Corp Financial Flexibility Index by Year (2017–2024)
CannBioRx Life Sciences Corp financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for CannBioRx Life Sciences Corp. For the full cash flow conversion analysis, see ATNFW operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.42x | $-1.48 Million | $-1.48 Million | $3.51 Million | ▲ +79.2% |
| 2023 | -2.03x | $-10.92 Million | $-10.92 Million | $5.39 Million | ▼ -38.9% |
| 2022 | -1.46x | $-12.13 Million | $-12.13 Million | $8.31 Million | ▼ -782.0% |
| 2021 | -0.17x | $-3.87 Million | $-3.87 Million | $23.39 Million | ▼ -7.9% |
| 2020 | -0.15x | $-3.87 Million | $-3.87 Million | $25.25 Million | ▲ +35.7% |
| 2019 | -0.24x | $-3.17 Million | $-3.32 Million | $13.31 Million | ▼ -43.7% |
| 2018 | -0.17x | $-758.40K | $-789.23K | $4.57 Million | ▼ -41.2% |
| 2017 | -0.12x | $-497.36K | $-497.36K | $4.23 Million | — |